Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693203011 | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3693204017 | Erythromycin 20 mg/mL cutaneous solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 46772301000001114 | Erythromycin 2% solution | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Is a | Product containing erythromycin in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has active ingredient | Erythromycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Conventional release cutaneous solution | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has basis of strength substance | Erythromycin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has precise active ingredient | Erythromycin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Is a | Product containing only erythromycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Is a | Erythromycin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Conventional release cutaneous solution | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solution.cutaneous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Topical route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has active ingredient | Erythromycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Cutaneous | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Liquid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Conventional release cutaneous solution | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Conventional release cutaneous solution | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Basic dose form with liquid state of matter | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Basic dose form with liquid state of matter | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has specific active ingredient | Erythromycin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has dispensed dose form | Basic dose form with liquid state of matter | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Basic dose form with liquid state of matter | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erythromycin 2% topical solution - product | Is a | False | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier | |
| Stiemycin 2% solution (Stiefel Laboratories Ltd) | Is a | True | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier | |
| Erythromycin 2% solution 50 ml | Is pack of | False | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier | |
| Stiemycin 2% solution (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier | |
| Erythromycin 2% solution 50 ml | Has VMP | True | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier | |
| Stiemycin 2% solution (Lexon (UK) Ltd) | Is a | True | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier | |
| Stiemycin 2% solution (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR